StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$20.98−0.16 (-0.76%)

Close on Nov 16, 2026Market cap $410.15MP/E –Yield 0.00%

Tectonic Therapeutic revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Tectonic Therapeutic

Tectonic Therapeutic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tectonic Therapeutic figures

See a number that looks wrong?